Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis.
Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple SclerosisImpact of Fingolimod Therapy in Multiple Sclerosis.
Oligodendrocytes and the early multiple sclerosis lesion.
Does glatiramer acetate provoke hepatitis in multiple sclerosis?
Intermittent feeding attenuates clinical course of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Neuronal NF-κB ablation does not influence neuro-axonal degeneration in experimental autoimmune demyelination.
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation.
Innovation at RUSH
MYRAC Rx
Central nervous system lymphoma associated with natalizumab.
Genzyme receives Complete Response Letter from FDA on Lemtrada™ (alemtuzumab) application
Gray matter is targeted in first-attack multiple sclerosis.
CD46: The 'multitasker' of complement proteins.
Natalizumab in the treatment of rheumatoid arthritis in subjects receiving methotrexate
Cyclophosphamide for multiple sclerosis.
MS and NMO: Partners No More.
Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients.
Electroacupuncture Promotes the Differentiation of Transplanted Bone Marrow Mesenchymal Stem Cells Pre-Induced with Neurotrophin-3 and Retinoic Acid into Oligodendrocyte-Like Cells in Demyelinated Spinal Cord of Rats.
Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort.
NAD⁺ in aging, metabolism, and neurodegeneration.
Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum.
Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV study.
IFN-β therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients.
The antiepileptic drug valproic acid restores T cell homeostasis and ameliorates pathogenesis of experimental autoimmune encephalomyelitis.
Slowing of brain atrophy and reductions in new multiple sclerosis lesions sustained at three years in patients treated with Genzyme's LemtradaTM

Pages